Growth Metrics

Pacific Biosciences Of California (PACB) Acquisitions (2021)

Pacific Biosciences Of California has reported Acquisitions over the past 1 years, most recently at $28.6 million for Q4 2021.

  • Quarterly results put Acquisitions at $28.6 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2024 was $28.6 million (changed N/A YoY), and the annual figure for FY2023 was $102000.0, changed.
  • Acquisitions for Q4 2021 was $28.6 million at Pacific Biosciences Of California.
  • Over the last five years, Acquisitions for PACB hit a ceiling of $28.6 million in Q4 2021 and a floor of $28.6 million in Q4 2021.